EVALUATION OF THREE CASES WITH ACUTE CORONARY SYNDROME CAUSED BY CORONARY THROMBUS
Öz
Coronary thrombus causes reduced blood flow in patients with acute myocardial infarction. Our aim was to to contribute to the understanding of the mechanisms of coronary occlusion caused by thrombus, evaluating the histopathological characteristics of thrombi in three cases. Cases were diagnosed with ST elevation type of myocardial infarction by coronary angiography. Histopathological analysis of thrombi as well as immunohistochemical staining with PTX3 (pentraxin 3, an acute phase protein) and CD68 (a cytokine released from monocyte and macrophages) were performed. Blood levels of troponin and PTX3 were also evaluated. The PTX3 immunostaining score was high in all cases but it was not consistent with its blood level. The high PTX3 staining intensity in the case with normal PTX3 blood level may be the result of rapid local release of PTX3. Case with highest PTX3 blood level had another inflammatory disease that could have driven this increase. We suggest that PTX3 and CD68 immunostainings can be used as a marker in the histopathological evaluation of coronary thrombus.
Anahtar Kelimeler
Kaynakça
- 1. Ambrose JA, Winters SL, Stern A, et al. Angiographic morphology and the pathogenesis of unstable angina pectoris. J Am Coll Cardiol. 1985;5(3):609-16.
- 2. Fuijkschot WW, Groothuizen WE, Appelman Y, et al. Inflammatory cell content of coronary thrombi is dependent on thrombus age in patients with ST-elevation myocardial infarction. J Cardiol. 2017;69(1):394-400.
- 3. Bottazzi B, Bastone A, Doni A, et al. The long pentraxin PTX3 as a link among innate immunity, inflammation, and female fertility. J Leukoc Biol. 2006;79(5):909-12.
- 4. Yunoki K, Naruko T, Sugioka K, et al. Thrombus aspiration therapy and coronary thrombus components in patients with acute ST-elevation myocardial infarction. J Atheroscler Thromb. 2013;20(6):524-37.
- 5. Bonacina F, Baragetti A, Catapano AL, et al. Long pentraxin 3: experimental and clinical relevance in cardiovascular diseases. Mediators Inflamm. 2013;2013:725102.
- 6. Savchenko A, Imamura M, Ohashi R, et al. Expression of pentraxin 3 (PTX3) in human atherosclerotic lesions. J Pathol. 2008;215:48-55.
- 7. Latini R, Maggioni AP, Peri G, et al. Lipid Assessment Trial Italian Network (LATIN) Investigators. Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction. Circulation. 2004;110(16):2349-54.
- 8. Maugeri N, Rovere-Querini P, Slavich M, et al. Correction: Early and transient release of leukocyte pentraxin 3 during acute myocardial infarction. J Immunol. 2011;187(12):970- 9.
Ayrıntılar
Birincil Dil
İngilizce
Konular
Klinik Tıp Bilimleri
Bölüm
Olgu Sunumu
Yazarlar
Bahadır Kırılmaz
0000-0002-5929-1426
Türkiye
Ertuğrul Ercan
Bu kişi benim
0000-0003-0480-4738
Türkiye
Yayımlanma Tarihi
18 Ekim 2021
Gönderilme Tarihi
29 Mayıs 2019
Kabul Tarihi
15 Nisan 2020
Yayımlandığı Sayı
Yıl 2021 Cilt: 22 Sayı: 6
